| 1. |
Rofecoxib cost-effectiveness study results debated |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
Counting the costs of MS |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 3-4
&NA;,
Preview
|
|
摘要:
Multiple sclerosis (MS) is a common, neurological autoimmune disease that affects approximately 400 000 individuals in the US alone. Its effects on patients' central nervous systems can be debilitating, and often result in chronic morbidity and disability, which takes a substantial financial toll on society. Several studies presented at the 9th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) [Arlington, Virginia, US; May 2004] considered the economic burden of MS, and the cost effects associated with drug treatments.
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Improved labelling, education required for safe OTC analgesic use |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
US paediatric healthcare needs improvement, says review |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Global economic model needed for pharmaceutical market? |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
CR oxybutynin cost effective for OAB in France, Austria and the UK |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
Nicotinic acid/lovastatin better value than simvastatin for lipid lowering |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Statins frequently prescribed with potentially interacting drugs |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
QOL approaches normal values with injectable risperidone |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Controversy over ritonavir price hike continues |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 455,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
